TrialJournal of cancer research and clinical oncology2017

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).

Juliane Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.